Bismuth-based quadruple Helicobacter pylori eradication regimen alters the composition of gut microbiota
Type of Spiritual Experience
A description of the experience
Infez Med. 2018 Jun 1;26(2):115-121.
Bismuth-based quadruple Helicobacter pylori eradication regimen alters the composition of gut microbiota.
Yildiz SS1, Yalinay M2, Karakan T3.
Public Health Institution of Turkey, Microbiology Reference Laboratories Department, National AMR Surveillance Laboratory, Sihhiye Ankara, Turkey.
Gazi University, Faculty of Medicine and Clinical Microbiology Department, Beşevler Ankara, Turkey.
Gazi University, Faculty of Medicine and Gastroenterology Department, Beşevler Ankara, Turkey.
Microbiota is a dynamic system showing individual differences in both the number and species of microorganisms. Dietary habits, lifestyle, age, genetic predisposition of the host and use of antibiotics are effective on microbiota. The aim of our research was to carry out a quantitative comparison of Bifidobacterium spp, Bacteroides fragilis, Lactobacillus spp, Akkermansia mucinophilia and Faecalibacterium prausnitzii, important bacterial microbiota species, before and after antibiotic therapy treated with tetracycline and metronidazole in patients who are diagnosed as positive for Helicobacter pylori (HP), and to determine the effects of antibiotic use on the microbiota.
Eighteen HP-positive patients were enrolled in this study. A special extraction kit (QIAmp DNA Stool Mini Kit, QIAgen, Germany) was used for the DNA isolation procedure. Primers specific to the 16S rRNA region of the bacteria included in the study were used for the amplification of the target region.
All the bacteria were subjected to real-time quantification procedure with PCR method on RotorGene® 20 device (Qiagen, Germany). According to quantification before and after antibiotic use in patients receiving HP treatment, statistically significant decreases were observed in Bifidobacterium spp (p=0.001), B. fragilis (p=0.001), Lactobacillus spp (p=0.001), A. mucinophilia (p=0.001) and F. prausnitzii (p=0.001). We were unable to identify B. fragilis in the microbiota of five patients after treatment.
Based on the data obtained, it can be concluded that antibiotics used to treat HP can prepare the ground that could result in dysbiosis in microbiota.